Laboratorios Richmond SACIF operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Laboratorios Richmond SACIF with three other
pharmaceutical manufacturers in Latin America:
Fleury SA
of BRAZIL
(2019
sales of 2.91 billion Brazilian Reals [US$522.22 million]
of which 84%
was Diagnostic Medicine),
Ouro Fino Saude Animal Participacoes SA
of BRAZIL
(619.59 million Brazilian Reals [US$111.38 million]
of which 75%
was Production Animals), and
Instituto Hermes Pardini SA
which is
also
based in BRAZIL
(1.35 billion Brazilian Reals [US$243.33 million]
of which 100%
was auxiliary diagnostic support services).
Sales Analysis.
During the year ended December of 2019, sales at
Laboratorios Richmond SACIF were 3.90 billion Argentinian Pesos (US$51.42 million).
This
is
an
increase of 114.4%
versus 2018, when the company's sales were 1.82 billion Argentinian Pesos .
This was the fifth consecutive year of sales increases at Laboratorios Richmond SACIF
(and since 2014, sales have increased a total of 1,040%).
Sales of Public Market saw an increase
of
184.3% in 2019, from
386.21 million Argentinian Pesos to 1.10 billion Argentinian Pesos .